• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

4-Cyclobutyl-4-Piperidinol (CAS No. 1374568-02-1): A Comprehensive Overview

4-Cyclobutyl-4-Piperidinol (CAS No. 1374568-02-1) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This compound, characterized by its unique cyclobutyl-piperidine structure, serves as a key intermediate in the synthesis of various bioactive molecules. Its molecular formula is C9H17NO, and it exhibits properties that make it valuable in drug discovery and material science applications.

The 4-cyclobutyl-4-piperidinol structure combines a piperidine ring with a cyclobutyl group, offering a rigid yet flexible framework for molecular design. This structural feature is particularly appealing in medicinal chemistry, where researchers seek to optimize drug candidates for improved binding affinity and metabolic stability. Recent studies highlight its potential in targeting central nervous system (CNS) disorders, a hot topic in pharmaceutical development due to the growing demand for novel neurological therapeutics.

One of the most searched questions related to 4-cyclobutyl-4-piperidinol is its role in small molecule drug discovery. Researchers frequently inquire about its synthetic routes, purity standards, and commercial availability. The compound's versatility allows it to serve as a building block for kinase inhibitors and GPCR modulators, two prominent classes of therapeutic agents. Its stability under various reaction conditions further enhances its utility in multi-step synthetic processes.

From a market perspective, the demand for high-purity 4-cyclobutyl-4-piperidinol has risen steadily, driven by increased R&D activities in pharmaceutical companies and academic institutions. Suppliers often emphasize its low impurity profile and scalable synthesis, addressing common concerns among buyers. The compound's compatibility with modern green chemistry principles also aligns with the industry's shift toward sustainable practices, a trending topic in chemical manufacturing.

Analytical characterization of 4-cyclobutyl-4-piperidinol typically involves advanced techniques such as HPLC, NMR spectroscopy, and mass spectrometry. These methods ensure batch-to-batch consistency and verify the absence of isomeric impurities, crucial for research reproducibility. The compound's physicochemical properties, including solubility and melting point, are frequently documented in technical datasheets to guide experimental design.

In material science applications, the cyclobutyl-piperidine scaffold demonstrates interesting properties for designing novel polymers and liquid crystals. Its conformational rigidity contributes to thermal stability, while the nitrogen atom offers sites for further functionalization. These characteristics make it a subject of investigation for advanced material development, particularly in electronics and coatings industries.

Safety considerations for handling 4-cyclobutyl-4-piperidinol follow standard laboratory protocols for organic compounds. While not classified as hazardous under normal conditions, proper personal protective equipment (PPE) is recommended during manipulation. Storage typically requires protection from moisture and oxidation, with many suppliers offering the compound in argon-protected packaging for extended shelf life.

The synthetic accessibility of 4-cyclobutyl-4-piperidinol derivatives has prompted numerous structure-activity relationship (SAR) studies. Medicinal chemists frequently modify the hydroxyl group or cyclobutyl moiety to explore new biological activities. This approach has yielded promising leads for pain management and neurodegenerative disease treatments, addressing critical unmet medical needs.

From a regulatory standpoint, 4-cyclobutyl-4-piperidinol currently faces no significant restrictions in most jurisdictions, facilitating its use in international research collaborations. However, researchers should verify local regulations before shipping or transferring the compound across borders. The absence of controlled substance classifications makes it particularly attractive for academic and industrial laboratories.

Future research directions for 4-cyclobutyl-4-piperidinol may explore its potential in bioconjugation chemistry and prodrug design, emerging areas in drug delivery systems. The compound's balanced lipophilicity and hydrogen bonding capacity position it well for these applications. Additionally, computational studies predicting its ADME properties could further validate its utility in preclinical development pipelines.

For procurement considerations, researchers often compare 4-cyclobutyl-4-piperidinol suppliers based on purity levels, packaging options, and technical support. Many vendors now provide custom synthesis services to accommodate specific research requirements, including isotopic labeling or chiral resolution. The compound's growing importance ensures its continued presence in catalogs of fine chemical distributors worldwide.

In conclusion, 4-cyclobutyl-4-piperidinol (CAS No. 1374568-02-1) represents a versatile scaffold with broad applications in pharmaceutical and material sciences. Its unique structural features, synthetic accessibility, and research potential maintain its status as a valuable tool for chemical innovation. As scientific understanding of its properties deepens, new applications will likely emerge across multiple disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)